CD44 and cancer: Given the proposed ITIH5-HA-C44 axis as main mechanism of cancer cell suppression, our data provide a rational why ITIH5 might be predominantly down-regulated in basal-type cancers, i.e., in those tumors known to be characterized by abundant CD44 expression.